These findings illustrate the complex regulatory dynamics of SOD1-G93A ALS require carefully timed combination treatments to modulate the correct category at the most appropriate time to optimally stabilize the system using realistic treatment effect sizes. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.